Curtis Rosebraugh - 23 Jun 2022 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Role
Director
Signature
/s/ Curtis Rosebraugh
Issuer symbol
ENSC
Transactions as of
23 Jun 2022
Net transactions value
$0
Form type
4
Filing time
27 Jun 2022, 17:38:35 UTC
Previous filing
04 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENSC Stock Option Award +20,000 +133% 35,000 23 Jun 2022 Common Stock 15,000 $0.4250 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 23, 2022, Mr. Rosebraugh was granted an option (the "Stock Option") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year.